• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Seeking sibling for Vyvgart, argenx files for FDA approval of subcutaneous efgartigimod

cafead

Administrator
Staff member
  • cafead   Sep 27, 2022 at 10:32: AM
via Argenx has filed for FDA approval of subcutaneous efgartigimod, keeping it on track to start selling the sibling of its existing intravenous generalized myasthenia gravis (gMG) treatment Vyvgart.

article source
 

<